SYNERGOS THERAPIES (SCOTLAND) LTD

💤Zombieactive
SC771676 · ltd · incorporated 2023-06-05
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Jun 2025
Net worth
£-7.5k
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (79/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
3 connected companies via shared directors
54
Filing history
6 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Negative net assets
Liabilities exceed assets by £7,490

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
-£7k
↓ 68% YoY
Current Assets
£765
↓ 1.3% YoY
Current Liabilities
-£7k-£6k-£4k-£3k-£878£775Jun 2024Jun 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-06-302024-06-30
Total assets£-614£-4.5k
Current assets£765£775
Net assets£-7.5k£-4.5k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (6 events)Click to expand
  1. 2026-03-04
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-02-24
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2023-07-06
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  4. 2023-06-05
    🏢
    Company incorporated
    As SYNERGOS THERAPIES (SCOTLAND) LTD
  5. 2023-06-05
    LEGAN, Stephen John appointed
    director
  6. 2023-06-05
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

75/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mr Stephen John Legan
Individual · British · DOB 01/1971 · age 55
75100%
75–100%board control75-100% shares · 75-100% voting · board control05/06/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · G postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
OPTICAL EXPRESS LIMITED
SC161469 · est 1995
£80.82M
£58.19M£103.45M
5490030y8558y
GP MATTERS LIMITED
SC424457 · est 2012
£3.46M
£2.49M£4.43M
50014y8561y
GATE HEALTHCARE LIMITED
SC106549 · est 1987
£2.91M
£2.09M£3.72M
17838y8260y
LORIMER CARE HOMES LIMITED
SC412450 · est 2011
£2.26M
£1.63M£2.89M
014y8260y
GLENFAIRN LIMITED
SC087540 · est 1984
£1.83M
£1.32M£2.34M
8442y8260y
ASPIRE HOUSING & PERSONAL DEVELOPMENT SERVICES LIMITED
SC231773 · est 2002
£354.7k24y8377y
BCERTA LTD.
SC355831 · est 2009
17y8367y
COMMONWEALTH DENTAL PRACTICE LTD.
SC381148 · est 2010 · no financials extracted
15y8358y
DAVID LIVINGSTONE INTERNATIONAL LIMITED
SC118899 · est 1989
£150.4k36y8390y
DOON CARE LTD.
SC262088 · est 2004
£1.46M22y8387y
DUNDONALD HOUSE NURSING HOME LIMITED
SC296431 · est 2006
20y8364y
FORWARD STEPS NURSERY LTD.
SC235287 · est 2002
£59.0k23y8359y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-06-05
Jurisdictionscotland
Primary SIC86900 — Other human health activities

Registered office

2 West Regent Street
Glasgow
Lanarkshire
G2 1RW

Filing status

Accounts
Next due: 2027-03-31
Last made up to: 2025-06-30
Confirmation statement
Next due: 2026-06-18
Last: 2025-06-04

Officers (1 active · 0 resigned)

LEGAN, Stephen John
director · ~55y · appointed 2023-06-05
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (6 total)

accounts-with-accounts-type-micro-entity
accounts · AA
2026-03-04
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-06-23
accounts-with-accounts-type-micro-entity
accounts · AA
2025-02-24
confirmation-statement-with-updates
confirmation-statement · CS01
2024-07-11
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2023-07-06
incorporation-company
incorporation · NEWINC
2023-06-05